SOURCE: Cypress Bioscience, Inc.

Cypress Bioscience, Inc.

March 08, 2010 06:30 ET

Cypress Bioscience, Inc. to Present at Cowen and Company 30th Annual Health Care Conference

SAN DIEGO, CA--(Marketwire - March 8, 2010) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Cowen and Company 30th Annual Health Care Conference on March 10, 2010.

The Cowen conference is being held at the Boston Marriott Copley Place Hotel in Boston, MA. Ms. Johnson is scheduled to present on Wednesday, March 10th at 8:00am Eastern Time. The audio broadcast of this presentation can be accessed at

A replay of the presentation will be available at the same web address as well as on Cypress' website,

About Cypress Bioscience
Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella® (milnacipran HCI) and the Avise PGSM and Avise MCVSM therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at

Contact Information

  • For additional information please contact

    Mary Gieson
    Investor Relations Manager
    (858) 452-2323
    Email Contact